Community Academic Profiles

Sanjeev Dutta, MD MA FRCSC FACS

Sutureless vs Sutured Gastroschisis Closure

Contact Information

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Sanjeev Dutta (650) 723-6439

Secondary Contact:

Susan Hintz (650) 497-8800
To view all clinical trials at Stanford, please see the Clinical Trials Directory.

Brief

This study aims to prospectively assess outcomes of sutureless versus sutured gastroschisis closure with a randomized control trial. The parameters of this trial were determined using our retrospective study as pilot data. Primary outcome measures will be time on ventilator and time to initiating enteral feeds. Other outcome measures will include cosmetic outcome, length of hospital stay and the associated rate of complications, including bowel resection, sepsis, and death.

Recruiting Status:

Not yet recruiting

Stanford Recruiting Status:

Not yet recruiting

Condition(s):

Intervention(s):

  • Procedure: Sutureless gastroschisis closure

Phase:

N/A

Eligibility

Ages Eligible for Study:

Any Age to Any Age

Genders Eligible for Study:

Male and Female

Health of Volunteers:

People with the conditions listed in this trial can participate as controls.

Key Inclusion Criteria:

Inclusion criteria are the diagnosis of gastroschisis, birth weight of 1500 grams or greater, and gestational age of 34 weeks or more.

Key Exclusion Criteria:

Exclusion criteria are infants with other major abnormalities or medical conditions, grade IV intraventricular hemorrhage, inability to obtain informed consent, and the presence of a closed-type gastroschsis defect.

Additional Study Details

Official Title:

Sutureless vs Sutured Gastroschisis Closure

Anticipated start date:

11/16/2009

Lead Sponsor:

Stanford University

Investigator(s):

Study Type:

Interventional

Purpose:

Treatment

Allocation:

Randomized

Masking:

Open

Control:

Assignment:

Parallel

Endpoints:

Efficacy

Primary Outcomes:

  • Time on ventilator
  • Time to initiating enteral feeds

Secondary Outcomes:

  • Cosmesis
  • Length of hospital stay
  • Complications including bowel resection, sepsis, and death.

Total Number to be Enrolled:

54

Total Number to be Enrolled at Stanford:

54

More Information

Trial Unique Id: SU-10142009-4180

Secondary ID(s):

  • IRB Protocol: 16918

Locations & Contacts

Stanford Locations & Contacts:

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Sanjeev Dutta (650) 723-6439

Secondary Contact:

Susan Hintz (650) 497-8800

Non-Stanford Locations:

The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.

This listing was last updated:

10/26/2009

PLEASE NOTE:

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.

Stanford Medicine Resources:

Footer Links: